The ELSA trial: single versus combinatory effects of non-prohibited beta-2 agonists on skeletal muscle metabolism, cardiopulmonary function and endurance performance-study protocol for a randomized 4-way balanced cross-over trial

Erstveröffentlichung

2021

Authors

Zügel, Martina

Bizjak, Daniel A.

Nussbaumer, Dorle

Winkert, Kay

Takabayashi, Kensuke

et al.

Wissenschaftlicher Artikel

Published in

Trials ; 22 (2021). - Art.-Nr. 903. - eISSN 1745-6215

Link to publication

https://dx.doi.org/10.1186/s13063-021-05862-w

Faculties

Medizinische Fakultät

Institutions

Sektion Sport- und Rehabilitationsmedizin
Institut für Epidemiologie und Medizinische Biometrie

Subject headings

[Free subject headings]: Beta-2 agonists | Asthma sprays | Asthma | Exercise | Anti-doping | Endurance performance | Ergogenic effects | WADA | Skeletal muscle/blood biomarkers | Cardiopulmonary function | Randomized controlled trial | EXERCISE-INDUCED BRONCHOSPASM | DRY-POWDER INHALATION | SALBUTAMOL | FORMOTEROL | BLOOD | URINE
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record